Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification

Morten Baltzer Houlind; Luise Hansen; Esben Iversen; Henrik Berg Rasmussen; Jens Borggaard Larsen; Steffen Jørgensen; Kim Dalhoff; Per Damkier; Anne B Walls; Charlotte Vermehren; Trine Rune Høgh Andersen; Thomas Kallemose; Lona Christrup; Niels Westergaard

doi:10.1111/bcpt.13990

Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification

Morten Baltzer Houlind^*
, Luise Hansen
, Esben Iversen
, Henrik Berg Rasmussen
, Jens Borggaard Larsen
, Steffen Jørgensen
, Kim Dalhoff
, Per Damkier
, Anne B Walls
, Charlotte Vermehren
, Trine Rune Høgh Andersen
, Thomas Kallemose
, Lona Christrup
, Niels Westergaard

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Pages (from-to)	756-763
Number of pages	8
Journal	Basic and Clinical Pharmacology and Toxicology
Volume	134
Issue number	5
Early online date	25 Feb 2024
DOIs	https://doi.org/10.1111/bcpt.13990
Publication status	Published - May 2024

Access to Document

10.1111/bcpt.13990

Cite this

Houlind, M. B., Hansen, L., Iversen, E., Rasmussen, H. B., Larsen, J. B., Jørgensen, S., Dalhoff, K., Damkier, P., Walls, A. B., Vermehren, C., Andersen, T. R. H., Kallemose, T., Christrup, L., & Westergaard, N. (2024). Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic and Clinical Pharmacology and Toxicology, 134(5), 756-763. https://doi.org/10.1111/bcpt.13990

@article{fa0aa8f8f24c4e6baaa867b5eec7e72e,

title = "Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification",

author = "Houlind, \{Morten Baltzer\} and Luise Hansen and Esben Iversen and Rasmussen, \{Henrik Berg\} and Larsen, \{Jens Borggaard\} and Steffen J{\o}rgensen and Kim Dalhoff and Per Damkier and Walls, \{Anne B\} and Charlotte Vermehren and Andersen, \{Trine Rune H{\o}gh\} and Thomas Kallemose and Lona Christrup and Niels Westergaard",

year = "2024",

month = may,

doi = "10.1111/bcpt.13990",

language = "English",

volume = "134",

pages = "756--763",

journal = "Basic and Clinical Pharmacology and Toxicology",

issn = "1742-7835",

publisher = "Wiley-Blackwell",

number = "5",

}

Houlind, MB, Hansen, L, Iversen, E, Rasmussen, HB, Larsen, JB, Jørgensen, S, Dalhoff, K, Damkier, P, Walls, AB, Vermehren, C, Andersen, TRH, Kallemose, T, Christrup, L & Westergaard, N 2024, 'Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification', Basic and Clinical Pharmacology and Toxicology, vol. 134, no. 5, pp. 756-763. https://doi.org/10.1111/bcpt.13990

Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. / Houlind, Morten Baltzer; Hansen, Luise; Iversen, Esben et al.
In: Basic and Clinical Pharmacology and Toxicology, Vol. 134, No. 5, 05.2024, p. 756-763.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark

T2 - Agreement between publicly funded genotyping tests and the subsequent phenotype classification

AU - Houlind, Morten Baltzer

AU - Hansen, Luise

AU - Iversen, Esben

AU - Rasmussen, Henrik Berg

AU - Larsen, Jens Borggaard

AU - Jørgensen, Steffen

AU - Dalhoff, Kim

AU - Damkier, Per

AU - Walls, Anne B

AU - Vermehren, Charlotte

AU - Andersen, Trine Rune Høgh

AU - Kallemose, Thomas

AU - Christrup, Lona

AU - Westergaard, Niels

PY - 2024/5

Y1 - 2024/5

U2 - 10.1111/bcpt.13990

DO - 10.1111/bcpt.13990

M3 - Article

C2 - 38403838

SN - 1742-7835

VL - 134

SP - 756

EP - 763

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

IS - 5

ER -